Targeting Lipoprotein Biogenesis: Considerations towards Antimicrobials

Area of Science:

• Microbiology
• Biochemistry
• Pharmacology

Background:

• No new antibiotic classes have been approved in decades, hindering the fight against antimicrobial resistance.
• Drug discovery efforts have stalled due to significant obstacles.
• Lipoprotein maturation pathways are critical for bacterial virulence and represent a promising target for novel antibiotics.

Purpose of the Study:

• To establish considerations and priority-setting for key lipoprotein processing enzymes (Lgt, LspA, and Lnt).
• To support the rational design of selective drugs targeting bacterial lipoprotein maturation.
• To identify optimal targets for developing new antibiotics against resistant bacteria.

Main Methods:

• Review of microbiology, biochemistry, structural biology, chemical design, and pharmacology data.
• Analysis of the roles of Lgt, LspA, and Lnt in lipoprotein processing.
• Evaluation of potential drug candidates' impact on bacterial species.

Main Results:

• The lipoprotein maturation pathway is a viable strategy for novel antibiotic development.
• LspA emerges as a highly promising target due to its critical role and potential for selective drug design.
• While not universally effective, drug candidates targeting this pathway show potential against resistant strains.

Conclusions:

• Targeting bacterial lipoprotein processing enzymes offers a new avenue for antibiotic discovery.
• LspA is a prioritized target for developing next-generation antibiotics effective against multidrug-resistant pathogens.
• Further research into LspA inhibitors could lead to urgently needed treatments for bacterial infections.